A 2018 study only found CD4+ T-cells to be significantly associated with overall survival in LGSOC [93], while the presence of intraepithelial CD8+ T-cells was not associated with improved survival in endometrioid or clear cell carcinomas [95]. The gene discussed is CD4; the disease is clear cell adenocarcinoma.